216 related articles for article (PubMed ID: 18295258)
1. Electrical impedance spectroscopy of benign and malignant prostatic tissues.
Halter RJ; Schned A; Heaney J; Hartov A; Schutz S; Paulsen KD
J Urol; 2008 Apr; 179(4):1580-6. PubMed ID: 18295258
[TBL] [Abstract][Full Text] [Related]
2. Genetic and least squares algorithms for estimating spectral EIS parameters of prostatic tissues.
Halter RJ; Hartov A; Paulsen KD; Schned A; Heaney J
Physiol Meas; 2008 Jun; 29(6):S111-23. PubMed ID: 18544804
[TBL] [Abstract][Full Text] [Related]
3. Electrical impedance spectroscopy of the human prostate.
Halter RJ; Hartov A; Heaney JA; Paulsen KD; Schned AR
IEEE Trans Biomed Eng; 2007 Jul; 54(7):1321-7. PubMed ID: 17605363
[TBL] [Abstract][Full Text] [Related]
4. Electrical properties of prostatic tissues: I. Single frequency admittivity properties.
Halter RJ; Schned A; Heaney J; Hartov A; Paulsen KD
J Urol; 2009 Oct; 182(4):1600-7. PubMed ID: 19683745
[TBL] [Abstract][Full Text] [Related]
5. A real-time electrical impedance sensing biopsy needle.
Mishra V; Bouayad H; Schned A; Hartov A; Heaney J; Halter RJ
IEEE Trans Biomed Eng; 2012 Dec; 59(12):3327-36. PubMed ID: 22929364
[TBL] [Abstract][Full Text] [Related]
6. Electrical property sensing biopsy needle for prostate cancer detection.
Mishra V; Schned AR; Hartov A; Heaney JA; Seigne J; Halter RJ
Prostate; 2013 Nov; 73(15):1603-13. PubMed ID: 23996675
[TBL] [Abstract][Full Text] [Related]
7. Electrical properties of prostatic tissues: II. Spectral admittivity properties.
Halter RJ; Schned A; Heaney J; Hartov A; Paulsen KD
J Urol; 2009 Oct; 182(4):1608-13. PubMed ID: 19683743
[TBL] [Abstract][Full Text] [Related]
8. Prostate Cancer Detection Using Composite Impedance Metric.
Khan S; Mahara A; Hyams ES; Schned AR; Halter RJ
IEEE Trans Med Imaging; 2016 Dec; 35(12):2513-2523. PubMed ID: 27305670
[TBL] [Abstract][Full Text] [Related]
9. Electrical impedance spectroscopy for prostate cancer diagnosis.
Mishra V; Bouayad H; Schned A; Heaney J; Halter RJ
Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():3258-61. PubMed ID: 23366621
[TBL] [Abstract][Full Text] [Related]
10. Transrectal sonography of benign and malignant prostatic lesions.
Burks DD; Drolshagen LF; Fleischer AC; Liddell HT; McDougal WS; Karl EM; James AE
AJR Am J Roentgenol; 1986 Jun; 146(6):1187-91. PubMed ID: 2422909
[TBL] [Abstract][Full Text] [Related]
11. The feasibility of prostate cancer detection by triple spectroscopy.
Salomon G; Hess T; Erbersdobler A; Eichelberg C; Greschner S; Sobchuk AN; Korolik AK; Nemkovich NA; Schreiber J; Herms M; Graefen M; Huland H
Eur Urol; 2009 Feb; 55(2):376-83. PubMed ID: 18359147
[TBL] [Abstract][Full Text] [Related]
12. Passive bioelectrical properties for assessing high- and low-grade prostate adenocarcinoma.
Halter RJ; Schned AR; Heaney JA; Hartov A
Prostate; 2011 Dec; 71(16):1759-67. PubMed ID: 21520155
[TBL] [Abstract][Full Text] [Related]
13. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.
Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P
Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458
[TBL] [Abstract][Full Text] [Related]
14. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.
Harden SV; Guo Z; Epstein JI; Sidransky D
J Urol; 2003 Mar; 169(3):1138-42. PubMed ID: 12576869
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of separation between ex vivo prostatic malignant and benign tissue using electrical impedance spectroscopy and electrical impedance tomography.
Murphy EK; Mahara A; Khan S; Hyams ES; Schned AR; Pettus J; Halter RJ
Physiol Meas; 2017 Jun; 38(6):1242-1261. PubMed ID: 28282026
[TBL] [Abstract][Full Text] [Related]
16. Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate.
Shah IA; Schlageter MO; Stinnett P; Lechago J
Mod Pathol; 1991 Mar; 4(2):220-4. PubMed ID: 1710806
[TBL] [Abstract][Full Text] [Related]
17. On conductivity, permittivity, apparent diffusion coefficient, and their usefulness as cancer markers at MRI frequencies.
Hancu I; Roberts JC; Bulumulla S; Lee SK
Magn Reson Med; 2015 May; 73(5):2025-9. PubMed ID: 24946752
[TBL] [Abstract][Full Text] [Related]
18. Measurement of tissue mechanical characteristics to distinguish between benign and malignant prostatic disease.
Phipps S; Yang TH; Habib FK; Reuben RL; McNeill SA
Urology; 2005 Aug; 66(2):447-50. PubMed ID: 16098374
[TBL] [Abstract][Full Text] [Related]
19. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
[TBL] [Abstract][Full Text] [Related]
20. A broadband high-frequency electrical impedance tomography system for breast imaging.
Halter RJ; Hartov A; Paulsen KD
IEEE Trans Biomed Eng; 2008 Feb; 55(2 Pt 1):650-9. PubMed ID: 18270001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
